Stephen A. Hill's Insider Trades & SAST Disclosures
Stephen A. Hill's most recent trade in Lipocine Inc was a trade of 7,500 Common Stock done . Disclosure was reported to the exchange on Dec. 16, 2020.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen A. Hill.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lipocine Inc | Stephen A. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 7,500 | 12,750 (0%) | 0% | 0 | Common Stock | |
| Lipocine Inc | Stephen A. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 7,500 | 7,500 | - | - | Restricted Stock Unit | |
| Cellectar Biosciences Inc | Stephen A. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 50,000 | 50,000 | - | - | Stock option (right to buy) | |
| Lipocine Inc | Stephen A. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 22,000 | 22,000 | - | - | Stock Options (Right to Buy) | |
| Cellectar Biosciences Inc | Stephen A. Hill | Director | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 04 Jun 2020 | 18,000 | 18,000 (0%) | 0% | 1.1 | 19,438 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges